Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Illinois Cancer Care

## Sitemaps
- [XML Sitemap](https://illinoiscancercare.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Pages
- [CancerCare Connect](https://illinoiscancercare.com/cancercare-connect/): When you're facing a possible cancer diagnosis, waiting for answers can feel overwhelming. At Illinois CancerCare, we understand the urgency, uncertainty and emotions that come with not knowing what comes next.
- [App Interest Form](https://illinoiscancercare.com/careers/app/): Are you an APP looking to make an impact at Illinois CancerCare?
- [New Patient Video Library](https://illinoiscancercare.com/patients/video-library/): Get to know Illinois CancerCare before your first visit. These videos offer a helpful overview of what to expect, from meeting members of your care team to learning about patient resources, appointment preparation, treatment support, and the services available to patients and families throughout each step of the care journey.
- [Patient Updates](https://illinoiscancercare.com/patient-updates/): Payments for Retail Pharmacy Prescriptions can be made over the phone at 309-243-3404. Payments can also be made with Visa, Mastercard, Discover or in person with a check or money order at any of our Illinois CancerCare Retail Pharmacy locations.
- [Non-Discrimination Policy](https://illinoiscancercare.com/patients/non-discrimination-policy/): Illinois CancerCare complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. Illinois CancerCare does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex.
- [Authorization Release](https://illinoiscancercare.com/patients/authorization-release/): Authorization For Release of Confidential Health Information Want to save or print this form?
- [Hodgkin’s Lymphoma](https://illinoiscancercare.com/cancer/cancer-types/hodgkins-lymphoma/)
- [Resources](https://illinoiscancercare.com/resources/): Having access to reliable information can make all the difference. Illinois CancerCare provides a range of resources to help you better understand your care, manage next steps, and find additional support. Browse the sections below for educational materials, helpful tools, and trusted information designed to guide you along the way.
- [Research](https://illinoiscancercare.com/research/): Illinois CancerCare Research Brochure Clinic Virtual Tour – Illinois CancerCare | Peoria, IL https://www.youtube.com/watch?v=Hy0PKKAppmk
- [Illinois CancerCare Genetics](https://illinoiscancercare.com/genetic-testing/): Coming soon...
- [Ask a Researcher](https://illinoiscancercare.com/clinical-trials/ask-a-researcher/): Welcome to Illinois CancerCare’s “Ask A Researcher” page. Do you have a specific question about the available research programs at Illinois CancerCare? You may ask your question by submitting the form below, and one of our researchers will respond to your request as soon as possible. You may also contact us at 309-243-3605.
- [Clinical Trials 101](https://illinoiscancercare.com/clinical-trials/clinical-trials-101/): A clinical trial is a research study designed to evaluate how well a new medical approach works in people. As a patient at Illinois CancerCare, you may have the opportunity to participate in a clinical trial that offers access to innovative, cutting‑edge treatment options.
- [Financial Conflict of Interest Disclosures & Policy](https://illinoiscancercare.com/clinical-trials/fcoi-disclosures-policy/): Standard Operating Policy: SOP-3.1-NCORP-001-01
- [Illinois CancerCare Research Leadership Team](https://illinoiscancercare.com/clinical-trials/leadership/): Director of Research
- [Research in the News](https://illinoiscancercare.com/clinical-trials/news/): February 13, 2026
- [Research Resource Center](https://illinoiscancercare.com/clinical-trials/resources/): When many people hear the term cancer research, they think only of new drug development. In reality, clinical research spans the full spectrum of care, from prevention and early detection to treatment, supportive care, and survivorship.
- [Stories](https://illinoiscancercare.com/stories/): What unites us at Illinois CancerCare is our pledge that no one in central Illinois should ever battle cancer alone. Each patient’s journey is unique. Our care teams work diligently to ensure the highest level of care, access to clinical research and treatments close to home. Yet, it is our patient’s that continue to inspire as they show perseverance, resilience, and strength.
- [Laboratory Service](https://illinoiscancercare.com/about/lab/): Our Illinois CancerCare laboratory team provides timely, accurate testing to support your care. We know lab work can feel overwhelming – we’re here to make the process as simple and comfortable as possible.
- [Volunteer](https://illinoiscancercare.com/volunteer/): Make a meaningful difference for patients and caregivers by joining our compassionate care team.
- [Insurance & Billing](https://illinoiscancercare.com/patients/insurance-billing/): As a new patient, you will need to complete a new patient information form along with verifying your current insurance. Please bring a copy of all insurance cards and a photo ID. We will need to make photo copies and place in your chart. If you have more than one insurance, please advise which should be primary in order to avoid any delays in processing claims. If you have a HMO or PPO plan, please verify Illinois CancerCare is in network with your insurance. Also, if you have any changes in coverage, please contact the Business Office right away. We will need to verify is pre-authorization or pre-certification is needed prior to any upcoming appointments.
- [Getting A Second Opinion](https://illinoiscancercare.com/patients/second-opinion/): At Illinois CancerCare, we support and encourage patients who wish to seek a second opinion regarding their diagnosis or treatment plan. To help you navigate this process, please review the guidelines below.
- [FAQ](https://illinoiscancercare.com/patients/faq/): Hours vary by location. Your care team will help schedule your lab collection and/or procedure at the location most convenient for you.
- [Drug Therapy Education](https://illinoiscancercare.com/patients/drug-therapy/): These short videos are designed to walk you through what to expect during your treatment, helping you feel more informed and prepared along the way. You don’t need to watch everything at once; take your time and explore the information at a pace that feels right for you.
- [Oncology Counseling Services](https://illinoiscancercare.com/patients/oncology-counseling/): I graduated with my Bachelor of Science degree from the University of Illinois at Urbana‑Champaign, where I double majored in psychology and sociology. I then earned my Master of Arts degree in Clinical Mental Health Counseling from Bradley University. After graduating from Bradley, I gained licensure as a Licensed Clinical Professional Counselor (LCPC) and became credentialed as a Fellow in Thanatology (FT).
- [FMLA / Disability](https://illinoiscancercare.com/patients/fmla-disability/): Please note: Forms require up to 14 days for processing. Leaving portions of this form blank could result in a delay in processing.
- [Cancer SurvivorCare](https://illinoiscancercare.com/patients/cancer-survivorcare/): We know there is a sense of comfort meeting regularly with your healthcare team at Illinois CancerCare.
- [Uterine Cancer](https://illinoiscancercare.com/cancer/cancer-types/uterine/): Uterine sarcoma is a rare cancer that starts in the muscle (myometrium) or supporting tissues of the uterus (womb) — not in the inner lining (endometrium). It behaves like other soft-tissue sarcomas and is approached differently than endometrial carcinoma.  
- [Thyroid Cancer](https://illinoiscancercare.com/cancer/cancer-types/thyroid/): Thyroid cancer begins when abnormal cells grow in the thyroid gland—a butterfly-shaped organ at the base of the neck that helps regulate metabolism, body temperature, heart rate, and calcium balance. Most thyroid nodules are benign, but some are cancerous and require treatment.  
- [Testicular Cancer](https://illinoiscancercare.com/cancer/cancer-types/testicular/): Testicular cancer begins when abnormal cells grow in one or both testicles (testes), the glands that produce testosterone and sperm. Almost all cases start in the germ cells that make sperm. These germ-cell tumors are broadly classified as seminomas and nonseminomas because they behave and are treated differently.  
- [Skin Cancer](https://illinoiscancercare.com/cancer/cancer-types/skin/): Skin cancer is the most common cancer in the United States. It develops when skin cells grow and divide abnormally, often due to damage from ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Many skin cancers are highly treatable when found early.
- [Sarcoma](https://illinoiscancercare.com/cancer/cancer-types/sarcoma/): Sarcomas are a rare, diverse group of cancers that arise from connective and supporting tissues—including muscle, fat, fibrous tissue, blood and lymph vessels, nerves, and bone. They can occur almost anywhere in the body and span many subtypes, most commonly grouped as soft tissue sarcomas and bone sarcomas. Certain sarcomas are site‑specific (e.g., uterine sarcoma) or virus‑driven (e.g., Kaposi sarcoma) and are managed with tailored approaches.
- [Kidney (Renal) Cancer](https://illinoiscancercare.com/cancer/cancer-types/renal/): Kidney cancer begins when cells in the kidney grow and divide in an uncontrolled way. The most common adult type is renal cell carcinoma (RCC), which starts in the tiny tubules that filter the blood; less common are urothelial (transitional cell) cancers of the renal pelvis/ureter, and childhood tumors such as Wilms tumor (managed separately). Kidney cancer is among the 10 most common cancers in the U.S.; risk increases with age and is higher in men than women.
- [Rectal Cancer](https://illinoiscancercare.com/cancer/cancer-types/rectal/): Coming soon...
- [Prostate Cancer](https://illinoiscancercare.com/cancer/cancer-types/prostate/): Prostate cancer begins when cells in the prostate (a walnut-sized gland below the bladder) grow and divide abnormally. It is the most common cancer in U.S. men after skin cancer, and risk rises with age. Most prostate cancers are found at a localized or regional stage and can often be treated successfully.  
- [Pancreatic Cancer](https://illinoiscancercare.com/cancer/cancer-types/pancreatic/): Pancreatic cancer arises when abnormal cells grow out of control in the pancreas, an organ that helps with digestion (exocrine function) and blood-sugar control (endocrine function). Most pancreatic cancers start in exocrine cells and are typically found at a later stage; pancreatic neuroendocrine tumors (PNETs) are less common and often have a different outlook and treatment approach.  
- [Ovarian Cancer](https://illinoiscancercare.com/cancer/cancer-types/ovarian/): Ovarian cancer refers to cancers that arise in the ovary, the fallopian tube, or the peritoneum (the lining of the abdomen); these epithelial cancers form in similar tissues and are staged and treated in similar ways. Most ovarian cancers are epithelial; less common types include germ cell and sex cord-stromal tumors, which have distinct behaviors and treatments.  
- [Non-Hodgkin’s Lymphoma](https://illinoiscancercare.com/cancer/cancer-types/non-hodgkins-lymphoma/): Non-Hodgkin lymphoma (NHL) is a group of blood cancers that begin in lymphocytes (white blood cells that are part of your immune system). NHLs can be indolent (slow-growing) or aggressive (fast-growing) and arise from B cells, T cells, or (less commonly) NK cells. Your exact subtype and stage guide testing, treatment, and follow-up.  
- [Myelodysplastic Syndrome](https://illinoiscancercare.com/cancer/cancer-types/myelodysplastic-syndrome/): Myelodysplastic syndromes (MDS) are a group of bone marrow cancers in which early blood forming cells (blasts) fail to mature into healthy red blood cells, white blood cells, and/or platelets. As a result, people develop cytopenias (low blood counts) that can cause anemia, infections, or bleeding; in some cases, MDS can progress to acute myeloid leukemia (AML).  
- [Multiple Myeloma](https://illinoiscancercare.com/cancer/cancer-types/multiple-myeloma/): Multiple myeloma (MM) is a cancer of plasma cells, a type of white blood cell that lives in the bone marrow and normally helps your body fight infection by making antibodies. In myeloma, abnormal plasma cells grow out of control and make a single, ineffective antibody (an “M-protein”), crowding out healthy blood-forming cells and affecting bones, kidneys, and the immune system.  
- [Mesothelioma](https://illinoiscancercare.com/cancer/cancer-types/mesothelioma/): Malignant mesothelioma is a rare cancer that starts in the mesothelium—the thin tissue lining the chest (pleura), abdomen (peritoneum), and less commonly the heart (pericardium) or testicles. Most U.S. cases involve the pleura (lining of the lungs and chest wall). Because every patient’s situation is unique, our team at Illinois CancerCare focuses on timely diagnosis, accurate staging, and personalized treatment plans designed to give you the best possible outcome.  
- [Melanoma](https://illinoiscancercare.com/cancer/cancer-types/melanoma/): Melanoma begins when pigment-making cells (melanocytes) develop DNA changes that cause uncontrolled growth. It most often starts on the skin, but it can also arise on mucous membranes or in the eye (uveal melanoma). Early detection is critical—most deaths from skin cancer are due to melanoma, but when found early, melanoma is highly treatable. Illinois CancerCare provides timely diagnosis, modern treatments, and supportive care tailored to you.  
- [Lung Cancer](https://illinoiscancercare.com/cancer/cancer-types/lung/): Lung cancer begins when abnormal cells in the lung grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)—each with different testing and treatment approaches.  
- [Liver Cancer](https://illinoiscancercare.com/cancer/cancer-types/liver/): Liver cancer begins when abnormal cells in the liver grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on timely diagnosis, accurate staging, and personalized treatment plans designed to give you the best possible outcome. In adults, the most common primary liver cancer is hepatocellular carcinoma (HCC); intrahepatic cholangiocarcinoma (bile duct cancer inside the liver) is the next most common. Cancers that spread to the liver from other organs are called metastatic (secondary) liver cancers and are treated based on where they started.  
- [Leukemia](https://illinoiscancercare.com/cancer/cancer-types/leukemia/): Leukemia is a cancer of the blood and bone marrow—the soft tissue inside bones where blood cells are made. It begins when early blood-forming cells develop DNA changes that cause them to grow and divide out of control. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on accurate diagnosis, modern risk-adapted treatment, and supportive care designed to give you the best possible outcome.  
- [Head & Neck Cancers](https://illinoiscancercare.com/cancer/cancer-types/head-neck/): Head and neck cancers begin when abnormal cells grow in areas such as the mouth (oral cavity), throat (pharynx), voice box (larynx), nasal cavity and paranasal sinuses, or salivary glands. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome.  
- [Stomach Gastric Cancer](https://illinoiscancercare.com/cancer/cancer-types/gastric/): Stomach (gastric) cancer begins when abnormal cells in the stomach lining grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome. Most stomach cancers in the U.S. are adenocarcinomas that arise from the inner lining (mucosa) of the stomach.  
- [Esophageal Cancer](https://illinoiscancercare.com/cancer/cancer-types/esophageal/): Esophageal cancer begins when abnormal cells in the esophagus grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome. The two most common types are adenocarcinoma and squamous cell carcinoma, which tend to occur in different parts of the esophagus and have different risk factors.  
- [Colorectal Cancer](https://illinoiscancercare.com/cancer/cancer-types/colorectal/): Colorectal cancer begins when abnormal cells in the colon or rectum grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome. Many colorectal cancers start as polyps—small growths that can be found and removed before they become cancer.
- [Cervical Cancer](https://illinoiscancercare.com/cancer/cancer-types/cervical/): Cervical cancer begins when abnormal cells in the cervix grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome. Nearly all cervical cancers are caused by persistent infection with certain high-risk human papillomavirus (HPV) types.  
- [Breast Cancer](https://illinoiscancercare.com/cancer/cancer-types/breast/): Breast cancer begins when abnormal cells in the breast grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome. Breast cancer can occur in women and men, though it is much more common in women.  
- [Brain Cancer](https://illinoiscancercare.com/cancer/cancer-types/brain/): Brain tumors begin when abnormal cells in the brain grow and divide in an uncontrolled way. Because every patient’s situation is unique, our team at Illinois CancerCare focuses on early detection, accurate diagnosis, and personalized treatment plans designed to give you the best possible outcome. Primary brain tumors start in the brain or spinal cord, while secondary (metastatic) brain tumors begin in another part of the body and spread to the brain. This page focuses on primary brain and central nervous system (CNS) tumors.  
- [When to Call the Doctor](https://illinoiscancercare.com/cancer/chemotherapy/call-the-doctor/): If you experience any new or worsening symptoms - especially fever, infection signs, uncontrolled vomiting, bleeding, chest pain, or severe weakness - contact your doctor right away. Here is your patient‑friendly, easy‑to‑use checklist for When to Call Your Doctor. This list is based on chemotherapy safety guidance from Illinois CancerCare.
- [Your Blood Counts](https://illinoiscancercare.com/cancer/chemotherapy/your-blood-counts/): Chemotherapy affects not only cancer cells but also healthy cells in your bone marrow, which make your blood cells. Because of this, your care team will monitor your blood counts regularly using a test called a Complete Blood Count (CBC). Keeping track of these numbers helps your provider make sure you are safe to continue treatment and helps prevent complications.
- [Managing Side Effects](https://illinoiscancercare.com/cancer/chemotherapy/side-effects/): Chemotherapy is an important tool used to treat cancer. While it helps destroy cancer cells, it can also affect some healthy cells in your body. This is why side effects can happen.
- [Chemotherapy Delivery](https://illinoiscancercare.com/cancer/chemotherapy/chemotherapy-delivery/): Chemotherapy can be delivered in several different ways. Your doctor will choose the method that works best for your specific cancer and treatment plan. Treatments may use one medication or a combination, and they are usually given in cycles - periods of treatment followed by time for your body to rest and recover.
- [Palliative Care](https://illinoiscancercare.com/cancer/palliative-care/): When facing an advanced or life-limiting illness, having the right support can make every step feel more manageable. Illinois CancerCare’s Palliative Care team works alongside patients, families and caregivers to help ease symptoms, support emotional well-being and guide care decisions based on what matters most to you. Our goal is to provide comfort, clarity and compassionate support throughout your cancer experience.
- [Chemotherapy](https://illinoiscancercare.com/cancer/chemotherapy/): Chemotherapy is any treatment involving the use of drugs to kill cancer cells. Cancer chemotherapy may consist of single drugs or combinations of drugs and can be administered through a vein, injected into a body cavity, or delivered orally in the form of a pill. Chemotherapy is different from surgery or radiation therapy in that the cancer-fighting drugs circulate in the blood to parts of the body where the cancer may have spread and can kill or eliminate cancer cells at sites great distances from the original cancer. As a result, chemotherapy is considered s systemic treatment.
- [Diagnostic Imaging](https://illinoiscancercare.com/cancer/imaging/): Advanced imaging plays a critical role in diagnosing cancer, guiding treatment decisions, and monitoring progress. At Illinois CancerCare, our Imaging Department provides high quality, on site imaging in a comfortable, convenient setting at many of our clinics - so your care stays coordinated with your oncology team.
- [Request a Pharmacy Refill](https://illinoiscancercare.com/pharmacy/refill/): Please complete all information below to submit and online refill. If you do not wish to complete information online, please refill your prescription by calling your Illinois CancerCare Pharmacy location:
- [Pharmacy](https://illinoiscancercare.com/pharmacy/): Please note: Effective May 1, 2025, Illinois CancerCare will no longer accept cash payments.
- [Quality Assurance](https://illinoiscancercare.com/quality/): At Illinois CancerCare, our Quality Assurance (QA) Department is committed to ensuring a safe, respectful, and high-quality experience for every patient, caregiver, and family member. We partner with patients and staff to continually improve our services, address concerns, and uphold privacy and safety standards across all locations.
- [Sunshine Award Nomination](https://illinoiscancercare.com/sunshine/): We need your help to recognize our employees who go the extra mile to brighten the lives of those around them. Please complete this form to share your story of how an Illinois CancerCare employee made a difference in your care or that of someone you know. THANK YOU!
- [Subscribe to Our Newsletter](https://illinoiscancercare.com/subscribe/): At Illinois CancerCare, we understand that cancer and blood disorders can impact countless lives. Subscribe to our newsletter to receive the latest updates on groundbreaking treatments, cutting-edge research, educational resources, our ongoing efforts to improve patient care in the fight against these conditions, and more.
- [Lab/Imaging Order Updates](https://illinoiscancercare.com/order-updates/): At Illinois CancerCare, our priority is to provide you with the safest, most accurate, and coordinated care possible. To support this, we are no longer able to accept or perform lab or imaging orders originating from outside providers. Please rest assured our facility is fully equipped to handle tests performed within our network.
- [My Patient Portal Login (Portal)](https://illinoiscancercare.com/portal/): Coming soon...
- [Ask HR](https://illinoiscancercare.com/ask-hr/)
- [Request/Change An Appointment](https://illinoiscancercare.com/appointment/): Our team is available Monday-Friday from 8AM-5PM.
- [Pharmaceutical Representatives (RXvantage)](https://illinoiscancercare.com/rxvantage/): As of 4/1/22:
- [New Patient Referrals](https://illinoiscancercare.com/referrals/): Select a referral option below to get started.
- [Your Visit](https://illinoiscancercare.com/patients/your-visit/): Understanding Your First Visit
- [Oncology Nutrition Programs & Services](https://illinoiscancercare.com/patients/oncology-nutrition/): I graduated from the University of Southern Indiana with a Bachelor of Science degree in Dietetics. I then moved to Peoria to complete my dietetic internship at OSF St. Francis Medical Center. Prior to starting this role, I worked as an inpatient clinical dietitian. I am Board Certified in Oncology Nutrition which means I specialize in nutrition for cancer patients.
- [Patient Information](https://illinoiscancercare.com/patients/): Coming soon...
- [Myelodysplastic Syndromes (MDS)](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/myelodysplastic-syndromes-mds/): Myelodysplastic syndromes (MDS) are a group of blood cancers in which bone marrow does not produce enough healthy blood cells. Instead, marrow stem cells form poorly developed or dysfunctional red cells, white cells, and/or platelets.
- [Multiple Myeloma](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/multiple-myeloma/): Multiple myeloma is a blood cancer of plasma cells, the white blood cells that normally make antibodies to fight infection.
- [Leukemia](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/leukemia/): Leukemia is a cancer that begins in the bone marrow, the soft tissue inside bones where blood cells are made. In leukemia, the marrow produces large numbers of abnormal blood cells, most often abnormal white blood cells, that enter the bloodstream and crowd out healthy cells.
- [Myelofibrosis](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/myelofibrosis/): Myelofibrosis is a rare bone marrow cancer in which scar tissue (fibrosis) replaces healthy bone marrow, making it difficult to produce normal blood cells.
- [Essential Thrombocythemia (ET)](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/essential-thrombocythemia/): Essential thrombocythemia is a myeloproliferative neoplasm (MPN) in which the bone marrow makes too many platelets, increasing the risk of blood clots (thrombosis) and, less commonly, abnormal bleeding. Many people are diagnosed after a routine blood test shows a high platelet count; some have no symptoms at first.
- [Polycythemia Vera](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/polycythemia-vera/): Polycythemia vera is a blood disorder in which the bone marrow makes too many red blood cells, and sometimes too many white blood cells and platelets. These extra blood cells thicken the blood and slow circulation, which can increase the risk of blood clots, heart attack, and stroke.
- [Aplastic Anemia](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/aplastic-anemia/): Aplastic anemia is a serious bone marrow failure disorder in which the bone marrow no longer produces enough new blood cells. This results in low red blood cells, white blood cells, and platelets, a condition called pancytopenia. The shortage of these cells causes fatigue, higher infection risk, and easy bleeding. Aplastic anemia can develop suddenly or gradually and may be mild, moderate, or severe.
- [Non-Hodgkin Lymphoma](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/non-hodgkin-lymphoma/): Non‑Hodgkin Lymphoma (NHL) is a cancer of the lymphatic system, which includes lymph nodes, bone marrow, spleen, and other immune tissues. NHL begins when a lymphocyte—usually a B‑cell, sometimes a T‑cell—undergoes genetic changes and starts growing uncontrollably.
- [Hodgkin Lymphoma](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/hodgkin-lymphoma/): Hodgkin lymphoma is a cancer of the immune system identified by the presence of the Reed–Sternberg cell, a hallmark seen on biopsy. It begins in B‑lymphocytes, the white blood cells responsible for producing antibodies.
- [Leukopenia](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/leukopenia/): Leukopenia means the body has fewer white blood cells (WBCs) than normal. Because WBCs help fight infection, a low count increases the risk of infections and may make it harder for the body to respond to illness.
- [Leukocytosis](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/leukocytosis/): Leukocytosis means the white blood cell (WBC) count is higher than normal. White blood cells are part of the immune system and help fight infection.
- [Hypercoagulable Disorders](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/hypercoagulable-disorders-thrombophilia/): A hypercoagulable disorder, also known as thrombophilia, is an inherited or acquired condition that makes the blood more likely to form blood clots. Normally, clotting is part of the body’s healing process, helping stop bleeding after injury. In hypercoagulable disorders, something goes wrong in this clotting process, leading to inappropriate or excessive clot formation, even without injury.
- [Thrombotic Thrombocytopenic Purpura (TTP)](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/thrombotic-thrombocytopenic-purpura-ttp/): Thrombotic Thrombocytopenic Purpura (TTP) is a rare but serious blood disorder in which blood clots form in small blood vessels throughout the body. These tiny clots use up platelets, lower platelet counts, and can block blood flow to vital organs, causing organ damage if not treated quickly. TTP is considered a medical emergency, but with prompt therapy, most people recover.
- [Immune Thrombocytopenic Purpura (ITP)](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/immune-thrombocytopenic-purpura-itp/): Immune Thrombocytopenic Purpura (ITP) is an autoimmune platelet disorder in which the body mistakenly attacks and destroys its own platelets that help stop bleeding. When platelet levels drop, people with ITP bruise easily and may bleed more than expected. ITP can be short‑term or long‑term, and while some people have very mild symptoms, others may experience more significant bleeding risks.
- [Hemochromatosis](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/hemochromatosis/): Hemochromatosis is a condition where the body absorbs too much iron, causing iron to build up in organs such as the liver, heart, pancreas, and joints. Because the body has no natural way to get rid of extra iron, levels gradually rise and eventually damage tissues if not treated.
- [Vitamin-Deficiency Anemias (B12 / B9)](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/vitamin-deficiency-anemias/): Vitamin‑deficiency anemias occur when the body doesn’t have enough vitamin B12 or folate (vitamin B9) to make healthy red blood cells. Without these vitamins, the body begins producing red blood cells that are too large and don’t work properly, reducing their ability to carry oxygen.
- [Anemia of Inflammation](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/anemia-of-inflammation/): Most cases are genetic, caused by mutations in the HFE gene, which regulates how much iron the intestines absorb. The most common mutation is C282Y, and people who inherit two copies (one from each parent) are at the highest risk of developing hereditary hemochromatosis.
- [What to Ask Your Doctor](https://illinoiscancercare.com/blood-disorders/ask-your-doctor/): Being educated and informed will help you make the best decisions about your blood disorder treatment. Get all the information you can as early as possible concerning your evaluation, treatment, and possible side effects. The sooner you know about side effects and possible treatments, the more likely you are to protect yourself against them or manage them more effectively.
- [Hematology Labs](https://illinoiscancercare.com/blood-disorders/hematology-labs/): Our on-site laboratory supports the diagnosis, monitoring, and treatment of blood disorders by providing timely and accurate testing. Many laboratory tests are performed in-house, allowing your care team to make informed decisions without unnecessary delays.
- [Benign Hematology Clinic](https://illinoiscancercare.com/blood-disorders/benign-hematology-clinic/): Our Benign Hematology Clinic providers have specialized training and expertise in diagnosing and managing non-cancerous blood disorders. Care is delivered by both physicians and Advanced Practice Providers (APPs).
- [Common Treatments](https://illinoiscancercare.com/blood-disorders/common-treatments/): Hematologic conditions affect blood and bone marrow in different ways, and treatment is highly individualized. Your care team will consider your specific diagnosis, blood counts, symptoms, overall health, and personal goals when developing your treatment plan. Some treatments are designed to address the underlying condition, while others help manage symptoms and support your body. Many patients receive a combination of approaches as part of their care.
- [What To Ask Your Doctor](https://illinoiscancercare.com/cancer/ask-your-doctor/): Your relationship with your doctor is an important part of your cancer care. You’ll have one main doctor who guides your treatment, explains your diagnosis, and helps you understand your options. It’s important that you feel comfortable asking questions and sharing your concerns.
- [Genetics Referral for Providers](https://illinoiscancercare.com/genetics/referral-for-providers/): Illinois CancerCare Genetics partners with referring clinicians to provide comprehensive genetic counseling, risk assessment, and testing for patients with personal or family histories suggestive of inherited cancer risk. Our program integrates national guidelines, clinical expertise, and research‑informed practices to support medical decision‑making across the continuum of care.
- [Genetics Process](https://illinoiscancercare.com/genetics/process/): We designed this process to be straightforward, supportive, and guided by the latest evidence.
- [Risk Assessment](https://illinoiscancercare.com/genetics/risk-assessment/): If you are concerned about inherited cancer risk because of your personal history, your family history, or both, we are here to help. We work with patients of all ages and backgrounds.
- [Genetics Clinic Appointment Request](https://illinoiscancercare.com/genetics/genetics-appointment/): You can request an appointment by completing the “Set Up Your Appointment” form on our homepage.
- [Genetics Clinics](https://illinoiscancercare.com/genetics/): About 20% of cancers are linked to inherited genetic changes passed down through families. Understanding your risk can help guide how you’re screened, monitored, and treated.
- [Erythrocytosis](https://illinoiscancercare.com/blood-disorders/blood-disorder-types/erythrocytosis/): Erythrocytosis means your body has too many red blood cells (erythrocytes). Red blood cells carry oxygen throughout the body, so having too many can make your blood thicker than normal. This may cause symptoms like headaches, fatigue, or—in more serious cases—increase the risk of blood clots. Your care team will determine the specific type of erythrocytosis you have, since different types have different causes and treatments.

## Doctors
- [Perdue, APP, Krystal](https://illinoiscancercare.com/doctors/krystal-perdue-app/)
- [Nemeth, APP, Mandie](https://illinoiscancercare.com/doctors/mandie-nemeth-app/)
- [Nelms, APP, Aletha](https://illinoiscancercare.com/doctors/aletha-nelms-app/)
- [MacDonald, APP, Melissa](https://illinoiscancercare.com/doctors/melissa-macdonald-app/)
- [Johnson, APP, Sim](https://illinoiscancercare.com/doctors/sim-johnson-app/)
- [Kitterman, APP, Andrew](https://illinoiscancercare.com/doctors/andrew-kitterman-app/)
- [Doubet, APP, Keith M.](https://illinoiscancercare.com/doctors/keith-m-doubet-app/)
- [Asad, M.D., M. Fahad B.](https://illinoiscancercare.com/doctors/m-fahad-b-asad-md/)
- [.Gerstner, M.D., Gregory J.](https://illinoiscancercare.com/doctors/gerstner-m-d-gregory-j-demo/)
- [.Asad, M.D., M. Fahad B.](https://illinoiscancercare.com/doctors/asad-m-d-m-fahad-b-demo/)
- [Nemeth, APP, Mandie L.](https://illinoiscancercare.com/doctors/nemeth-app-mandie-l/)
- [Gatz, APP, Lindsey](https://illinoiscancercare.com/doctors/lindsey-gatz-app/)
- [Reubin, APP, Courtney](https://illinoiscancercare.com/doctors/courtney-reubin-app/)
- [Montemayor, M.D., Daniel P.](https://illinoiscancercare.com/doctors/daniel-p-montemayor-md/)
- [Sauder, APP, Emma](https://illinoiscancercare.com/doctors/emma-sauder-app/)
- [Sekhon, MD, Sudhir S.](https://illinoiscancercare.com/doctors/sudhir-s-sekhon-md/)
- [Hinrichsen, APP, Melyssa](https://illinoiscancercare.com/doctors/melyssa-hinrichsen-app/)
- [Goodwin, APP, Jana](https://illinoiscancercare.com/doctors/jana-goodwin-app/)
- [Peters, D.O., Joseph R.](https://illinoiscancercare.com/doctors/joseph-r-peters-do/)
- [Youngman, APP, Laura](https://illinoiscancercare.com/doctors/laura-youngman-app/)
- [Mercer, APP, Flesscia](https://illinoiscancercare.com/doctors/flesscia-mercer-app/)
- [Linden, APP, Desirae](https://illinoiscancercare.com/doctors/desirae-linden-app/)
- [Barnes, APP, C. Nelle](https://illinoiscancercare.com/doctors/c-nelle-barnes-app/)
- [Todd, APP, Shelly](https://illinoiscancercare.com/doctors/shelly-todd-app/)
- [Baker, MD, Mari](https://illinoiscancercare.com/doctors/mari-baker-md/)
- [Katiyar, MD, Vatsala](https://illinoiscancercare.com/doctors/vatsala-katiyar-md/)
- [Kluesner, APP, Lauren](https://illinoiscancercare.com/doctors/lauren-kluesner-app/)
- [Yang, APP, Linda](https://illinoiscancercare.com/doctors/linda-yang-app/)
- [Hertz, APP, Laura](https://illinoiscancercare.com/doctors/laura-hertz-app/)
- [Dunahee, APP, CNP, LoriLee](https://illinoiscancercare.com/doctors/lorilee-dunahee-app-cnp/)
- [Willhardt, APP, Kate](https://illinoiscancercare.com/doctors/kate-willhardt-app/)
- [King, APP, Michelle L.](https://illinoiscancercare.com/doctors/michelle-l-king-app/)
- [Price, APP, Sarah](https://illinoiscancercare.com/doctors/sarah-price-app/)
- [Damarla, M.D., MPH, Vijay K.](https://illinoiscancercare.com/doctors/vijay-k-damarla-md-mph/):    
- [Scott, APP, Kim](https://illinoiscancercare.com/doctors/kim-scott-app/)
- [Riner, APP, Gina](https://illinoiscancercare.com/doctors/gina-riner-app/)
- [Mendaluk, APP, Jennifer](https://illinoiscancercare.com/doctors/jennifer-mendaluk-app/)
- [Lemmerman DNP-FNP, Jessie](https://illinoiscancercare.com/doctors/jessie-lemmerman-dnp-fnp/)
- [Kindred, APP, Kathie](https://illinoiscancercare.com/doctors/kathie-kindred-app/)
- [Stewart, APP, Kari](https://illinoiscancercare.com/doctors/kari-stewart-app/)
- [Grys, APP, Lindsey](https://illinoiscancercare.com/doctors/lindsey-grys-app/)
- [Berryman, APP, Elizabeth](https://illinoiscancercare.com/doctors/elizabeth-berryman-app/)
- [Delinski, APP, Holly Jo](https://illinoiscancercare.com/doctors/holly-jo-delinski-app/):    
- [Ku, M.D., Kimberly](https://illinoiscancercare.com/doctors/kimberly-ku-m-d/):    
- [Whalen, APP, Erin](https://illinoiscancercare.com/doctors/erin-whalen-app/)
- [Schertz, APP, Robin](https://illinoiscancercare.com/doctors/robin-schertz-app/)
- [Johnson, APP, Michelle](https://illinoiscancercare.com/doctors/michelle-johnson-app/)
- [Gamblin, APP, Jessica](https://illinoiscancercare.com/doctors/jessica-gamblin-app/)
- [Foreman, APP, Jodi](https://illinoiscancercare.com/doctors/jodi-foreman-app/)
- [Blodgett, APP, Rachel](https://illinoiscancercare.com/doctors/rachel-blodgett-app/)
- [Rehman, M.D., Nadia](https://illinoiscancercare.com/doctors/nadia-rehman-md/)
- [Williamson, APP, Judith L.](https://illinoiscancercare.com/doctors/judith-l-williamson-app/)
- [Riley, APP, Gloria (Jeannie) J.](https://illinoiscancercare.com/doctors/gloria-jeannie-j-riley-app/)
- [Veeder, M.D., Michael H.](https://illinoiscancercare.com/doctors/michael-h-veeder-m-d/)
- [Seibert, M.D., Shawn M.](https://illinoiscancercare.com/doctors/shawn-m-seibert-md/)
- [MacVicar, M.D., Gary](https://illinoiscancercare.com/doctors/gary-macvicar-md/)
- [Liu, M.D., Jane](https://illinoiscancercare.com/doctors/jane-liu-m-d/)
- [Le-Lindqwister, M.D., Nguyet A.](https://illinoiscancercare.com/doctors/nguyet-le-lindqwister-m-d/)
- [Kumar, M.D., Pankaj](https://illinoiscancercare.com/doctors/pankaj-kumar-m-d/)
- [Jujjavarapu, M.D., Srinivas](https://illinoiscancercare.com/doctors/srinivas-jujjavarapu-m-d/)
- [Gomez, M.D., Patrick L.](https://illinoiscancercare.com/doctors/patrick-l-gomez-m-d/)
- [Geoffroy, M.D., Francois J.](https://illinoiscancercare.com/doctors/francois-j-geoffroy-m-d/)
- [Fishkin, M.D., Paul A. S.](https://illinoiscancercare.com/doctors/paul-s-fishkin-md/)
- [Daily, APP, Tammy](https://illinoiscancercare.com/doctors/tammy-daily-app/)
- [Beach, APP, Debra](https://illinoiscancercare.com/doctors/debra-beach-app/)
- [Lindsey, APP, Sarah](https://illinoiscancercare.com/doctors/sarah-lindsey-app/)
- [Gerstner, M.D., Gregory J.](https://illinoiscancercare.com/doctors/gregory-j-gerstner-md/)
- [Bajaj, M.D., Madhuri](https://illinoiscancercare.com/doctors/madhuri-bajaj-md/)

## News Articles
- [Announcing our 2025 Employee of the Year!](https://illinoiscancercare.com/news/2025-employee-of-the-year/): We are proud to have a team full of outstanding Illinois CancerCare employees to help live out our mission of providing comprehensive, compassionate care that enhances the lives of our patients and their families.
- [IBC Meeting Minutes 12/18/25](https://illinoiscancercare.com/news/ibc-meeting-minutes-12-18-25/)
- [Cutting-Edge Clinical Trial Access](https://illinoiscancercare.com/news/cutting-edge-clinical-trial-access/): ILLINOIS CANCERCARE – BRINGS CUTTING-EDGE CLINICAL TRIAL ACCESS CLOSE TO HOME – 45+ years of Research
- [Virtual Series: Nutrition For Breast Cancer Survivors](https://illinoiscancercare.com/news/breastcancernutrition/): Join registered dietitian, Karen Pettengill, RDN, CSO, LDN for a free, three-part virtual nutrition series designed specifically for breast cancer survivors and/or caregivers.
- [Watermelon Feta Salad](https://illinoiscancercare.com/news/watermelon_feta_salad/): This watermelon feta salad is perfect for a hot summer day! Watermelon is one of the most hydrating fruits containing about 91% water. Try adding blueberries, avocado, and/or arugula to the salad for extra cancer fighting nutrients.
- [Exciting News! Illinois CancerCare Joins National Effort to Transform Cancer Care](https://illinoiscancercare.com/news/illinois_cancercare_eom/): We are proud to announce that Illinois CancerCare has been selected to participate in the Enhancing Oncology Model (EOM)—a groundbreaking national initiative led by the Center for Medicare and Medicaid Innovation (CMMI). This program is designed to improve the quality of cancer care while helping reduce healthcare costs for patients and families.
- [St. Patrick’s Day Recipe: Green Avocado Ranch Dip](https://illinoiscancercare.com/news/st-patricks-day-recipe-green-avocado-ranch-dip/): Avocados are a good source of monounsaturated fats, also known as our healthy fats, which can help reduce 'bad' cholesterol levels. Avocados are also packed with many nutrients including fiber, potassium and vitamin E.
- [Valentine’s Day Recipe: Raspberry Chia Pudding](https://illinoiscancercare.com/news/valentines-day-recipe-raspberry-chia-pudding/): ‘Tis the season to celebrate love, right? Show your body some affection with this lovely Valentine’s Day snack or dessert!
- [Announcing our 2024 Employee of the Year!](https://illinoiscancercare.com/news/2024employeeoftheyear/): We are proud to have a team full of outstanding Illinois CancerCare employees to help live out our mission of providing comprehensive, compassionate care that enhances the lives of our patients and their families.
- [Connor’s Story | 2024 CUREageous Survivor Spotlight](https://illinoiscancercare.com/news/connors-story/): https://www.youtube.com/watch?v=ZfiV7Z4NoaU
- [Dr. Ruff’s Story | From Patient to Survivor](https://illinoiscancercare.com/news/dr-ruffs-story/): https://www.youtube.com/watch?v=VDYnP46B1Ds
- [Holiday Brussel Sprouts Recipe](https://illinoiscancercare.com/news/december_recipe/): Our Oncology Dietitian, Karen Bevers, RDN, CSO, LDN, shared a festive side to add to your holiday table this year!
- [Lemon Lentil Salad with Feta](https://illinoiscancercare.com/news/lemon-lentil-salad-with-feta/): The American Institute for Cancer Research (AICR) recommends getting at least 30 grams of fiber each day as part of a healthy eating pattern to lower cancer risk. Sources of fiber include fruits, vegetables, whole grains, beans and lentils.
- [Healthy Snack Option](https://illinoiscancercare.com/news/healthy-snack-option/): Try this easy and delicious No-Bake Protein Ball recipe to incorporate flaxseed in your diet! A serving of flaxseed provides impressive amounts of nutrients and benefits including digestion and reduced cancer risk.
- [Caregivers: Caring For YOU, Too](https://illinoiscancercare.com/news/caregivers-caring-for-you-too/): A cancer diagnosis can impact more than just the patient - it often takes a toll on those who care for them.
- [Dan’s Story | 2023 CUREageous Survivor Spotlight](https://illinoiscancercare.com/news/dans-story/): Some people walk in the rain... Others just get wet.
- [Healthy Eating Around the Holidays](https://illinoiscancercare.com/news/healthy-eating-around-the-holidays/): We get it. Making healthy food choices during the holiday season is TOUGH! Parties galore, cozy movie nights, family celebrations... it's simply hard to resist those tasty treats.
- [Healthy Eating On A Budget](https://illinoiscancercare.com/news/healthy-eating-on-a-budget/): Making healthy food choices doesn’t have to break the bank!
- [Pancreatic Cancer Genetic Testing](https://illinoiscancercare.com/news/pancreatic-cancer-genetic-testing/): Illinois CancerCare is proud to work with Theresa Tracy Strive To Survive to provide genetic testing at NO CHARGE to all ALL first and second generation relatives of those diagnosed with pancreatic cancer... no matter your location!
- [5-4-3-2-1 Technique for Panic Attacks](https://illinoiscancercare.com/news/easing-panic-attacks/): When we are anxious or in the midst of a panic attack, our mind is everywhere but in the present moment. Seth Errion, MA, LPC NCC, our Oncology Counselor, shares the coping technique he shares with clients - patients, caregivers, family members, etc. The hope is to help ground yourself back to the now and hopefully reduce those ruminating thoughts.
- [A Young Cancer Survivor Shares Her Story of Hope](https://illinoiscancercare.com/news/kelsies_story/): When Kelsie Barnhart was diagnosed with breast cancer in 2018 at age 27, it didn’t define her identity and it didn’t dominate her life.
- [Pickleball Saved My Life](https://illinoiscancercare.com/news/pickleball-saved-my-life/): Pickleball is taking the nation by storm and has become extremely popular right here in central Illinois. Described by the USA Pickleball Association as fun, social, and friendly, the game’s rules are simple and  easy for beginners to learn. Using elements of tennis, badminton, and ping-pong, pickleball is played on a modified tennis court with paddles and a small wiffle-like ball.
- [Illinois CancerCare Featured at ASCO 2022](https://illinoiscancercare.com/news/illinois-cancercare-featured-at-asco-2022/): June 3 - 7, 2022 | The American Society of Clinical Oncology (ASCO) hosts its 2022 ASCO Annual Meeting in Chicago, IL. ASCO is the world’s leading professional organization of physicians and oncology professionals dedicated to conquering cancer through research, education, and quality patient care. Over 40,000 health professionals from around the world attend this annual meeting, both in person and virtually, to review and discuss cutting-edge cancer research, life-changing therapies, and state-of-the-art treatments.
- [A Day in the Life of… A Clinical Research Coordinator](https://illinoiscancercare.com/news/a-day-in-the-life-of-a-clinical-research-coordinator/): She is one of the people who spend their days contributing to the important research being done to develop new and better treatments, improved symptom and side effect management, and potential cures for some types of cancer.
- [Bringing the Best Cancer Care to Central Illinois: A Daughter’s Story](https://illinoiscancercare.com/news/bringing-the-best-cancer-care-to-central-illinois-a-daughters-story/): For a generation that grew up with the internet, where you can find nearly anything at the drop of a hat, there is a belief that the answer is out there - you just have to find it. So, when my dad was diagnosed with brain cancer, and I was 160 miles away working in downtown Chicago, I made it my mission to find the most advanced care for his diagnosis. CDs of MRI scans were overnighted to my office and sent to neurosurgeons, oncologists and radiation experts in Texas, Indiana, Minnesota, as well as left at front doors or personally handed off in Chicago. The prognosis was not good, but their insight and compassion gave me some clear goals. I had not fully thought through if my parents would prefer to stay at home. My only concern was finding the best treatment.
- [Missed cancer screenings leading to later diagnoses](https://illinoiscancercare.com/news/missed-cancer-screenings-leading-to-later-diagnoses/): PEORIA, Ill. (WMBD) — Many are overdue for their cancer screenings and it is leading to later stages of cancer diagnoses, according to a recent study.
- [November Recipe: Homemade Guacamole](https://illinoiscancercare.com/news/november-recipe-homemade-guacamole/): ······
- [October Recipe: Oat Flour Pumpkin Muffins](https://illinoiscancercare.com/news/october-recipe-oat-flour-pumpkin-muffins/): ······
- [September Recipe: Chicken, Mushroom, & Wild Rice Pilaf](https://illinoiscancercare.com/news/september-recipe-chicken-mushroom-wild-rice-pilaf/): ······
- [Illinois CancerCare Foundation Celebrates 20th Anniversary with Beautiful Tribute Garden](https://illinoiscancercare.com/news/illinois-cancercare-foundation-celebrates-20-years/): When you or a loved one receive a referral to Illinois CancerCare, it’s the start of a journey filled with many emotions. In the days leading up to your appointment, you may experience fear, confusion and anxiety. When you walk through the doors of our clinics, you will experience another more powerful emotion – HOPE.
- [August Recipe: Broccoli and Cauliflower Salad](https://illinoiscancercare.com/news/august-recipe-broccoli-cauliflower-salad/): As the summer months come to an end, you may be looking for a salad or side dish to bring to an end of season cookout. Try out this quick and easy Broccoli & Cauliflower Salad that requires minimal preparation and just a few ingredients!
- [July Recipe: Red, White & Blue Layered Dessert](https://illinoiscancercare.com/news/july-recipe-red-white-blue-layered-dessert/): Did you know that eating high-quality protein sources can help cancer patients heal tissues, maintain muscle and keep the immune system strong? If you are a cancer patient, consider adding healthy sources of protein to each of your meals! Protein is especially important to our bodies after surgery, radiation and chemotherapy.
- [Walking Toward Health and Happiness](https://illinoiscancercare.com/news/walking-toward-health-and-happiness/): In addition to scientific research that demonstrates the benefits of spending time outside, many people just instinctively understand the power of nature.
- [Illinois CancerCare Enrolls First Patients in the World in Two Separate Clinical Research Trials](https://illinoiscancercare.com/news/illinois-cancercare-enrolls-first-patients-in-the-world-in-two-separate-clinical-research-trials/): June 15, 2021 – Today Illinois CancerCare announced the enrollment of the first patients in the world on two clinical trials - one for patients with advanced lung cancer and another for patients with advanced kidney cancer. Clinical research trials give patients early access to new promising therapies years before they may be approved for widespread use. Our dedicated research team works hard to ensure that our patients not only have early access to these potentially life-changing treatment options, but many times first access!
- [Illinois CancerCare Featured at ASCO 2021](https://illinoiscancercare.com/news/illinois-cancercare-featured-at-asco-2021/): June 4 - 8, 2021 | The American Society of Clinical Oncology (ASCO) is hosting its 2021 ASCO Annual Meeting virtually. ASCO is the world’s leading professional organization of physicians and oncology professionals dedicated to conquering cancer through research, education, and quality patient care. Over 40,000 health professionals from around the world attend this annual meeting to review and discuss cutting-edge cancer research, life-changing therapies, and state-of-the-art treatments.
- [5 Myths About Clinical Trials – and the Truths You Need to Know](https://illinoiscancercare.com/news/5-myths-about-clinical-trials-and-the-truths-you-need-to-know/): Research holds the keys to improved treatment options and possible cancer cures. That’s why Illinois CancerCare is fully committed to offering access to important global clinical trials right here in Illinois.
- [Being Your Own Advocate Throughout Your Cancer Journey](https://illinoiscancercare.com/news/being-your-own-advocate/): Cancer patients are often advised to be their own advocate. But what does that mean? The word advocate is sometimes associated with protests, politics, and social issues. In the medical field, that couldn’t be further from the truth! Self-advocacy simply means taking an active role in your diagnosis and treatment. Your doctor provides medical knowledge and you provide your values and preferences. Together, you and your doctor form a team to create an optimal treatment plan.
- [Cinco de Mayo Recipe: Lentil Tacos](https://illinoiscancercare.com/news/cinco-de-mayo-recipe-lentil-tacos/): Cinco de Mayo has us craving Mexican cuisine... and maybe a margarita or two!
- [Journal of American Medical Association (JAMA) Publication](https://illinoiscancercare.com/news/journal-of-american-medical-association-jama-publication/): Dr. Pankaj Kumar - Published in Journal of American Medical Association (JAMA) – the most widely circulated general medical journal of peer-reviewed articles in the world.
- [Easter Recipe: Carrot Cake Oatmeal Squares](https://illinoiscancercare.com/news/easter-recipe-carrot-cake-oatmeal-squares/): Did you know that eating carrots is linked to a reduced risk of cancer AND improved eye health? You never see a bunny with glasses!
- [Lung Cancer Patients Living Longer Thanks to Clinical Trial!](https://illinoiscancercare.com/news/lung-cancer-patients-living-longer-thanks-to-clinical-trial/): According to newly published data from clinical research trial IMpower010, early stage non-small cell lung cancer patients that receive Tecentriq (atezolizumab) following surgery and chemotherapy, are living longer… cancer free! Treating lung cancer early, before it spreads, provides the best opportunity for a cure.
- [St. Patrick’s Day Recipe: Shamrock Greens Quiche](https://illinoiscancercare.com/news/st-patricks-day-recipe-shamrock-greens-quiche/): Celebrate St. Patrick's with some healthful greens - not just clovers!
- [The COVID Connection to Cancer Research](https://illinoiscancercare.com/news/the-covid-connection-to-cancer-research/): The concept of medical research has been thrust into the spotlight recently with the rapid roll-out of the COVID-19 vaccine. This provides us with a great opportunity to talk about the value of clinical research for many different aspects of healthcare, including innovative cancer treatment.
- [CCRD Award Announcements](https://illinoiscancercare.com/news/ccrd-award-announcements/): National Cancer Institute awards Heartland Cancer Research NCORP with a Certificate of Excellence for Exceptional Patient Enrollment for Cancer Care Delivery Trials 2019-2020.
- [How Genetic Testing Can Protect Your Family](https://illinoiscancercare.com/news/how-genetic-testing-can-protect-your-family/): Although many people think that Illinois CancerCare is the place you go for top-notch treatment – which is true – we’re also dedicated to helping individuals learn about their potential risk of inherited cancer.
- [Tips for a Happy and Healthy Holiday Season](https://illinoiscancercare.com/news/tips-for-a-happy-and-healthy-holiday-season/): The holidays are a time for making memories, reflecting on the past year and looking toward the future filled with hope. This year’s holiday season will look and feel a little different, so we’re sharing a few tips to help you enjoy yourself in a safe and healthy way.
- [OVERCOMER | Coach Karrie Redeker’s Story](https://illinoiscancercare.com/news/coach-karrie-redeker/): It was the start of Wednesday’s women's basketball practice at Illinois Central College - the team was on a high having just found out they were playing in the national tournament - and head coach Karrie Redeker picked up the phone to hear she had breast cancer.
- [Next Level Care with our Pharmacy Team](https://illinoiscancercare.com/news/next-level-care-with-our-pharmacy-team/): People are often surprised at the huge role the Illinois CancerCare Pharmacy team plays in a patient’s treatment. Yet, our highly trained pharmacy professionals are a crucial part of our collaborative approach to comprehensive cancer care.
- [Research at Illinois CancerCare leads to NEW standard of care in Leukemia that does not require chemotherapy.](https://illinoiscancercare.com/news/new-standard-of-care-in-leukemia/): Chemotherapy is slowly becoming a thing of the past as new, less toxic cancer treatments are becoming available. A National Cancer Institute sponsored clinical trial titled E1912  partnered with our local Illinois CancerCare and resulted in a major treatment advancement for chronic lymphocytic leukemia (CLL) patients, without the use of any chemotherapy drugs!
- [Recipes Perfect For Grilling Out](https://illinoiscancercare.com/news/recipes-perfect-for-grilling-out/): Things look a little different for everyone these days. Cancer patients especially have to take extra precaution when it comes to venturing outside of the home. As appealing as eating out at a restaurant may sound, sometimes it's just not the wisest decision.
- [Clinical Oncology Research – Access to World Class Care Close to Home](https://illinoiscancercare.com/news/world-class-care-close-to-home/): Illinois CancerCare Research Journey – Dr. Edward Colloton https://youtu.be/lGqTbEKq6aQ
- [Illinois CancerCare Presents at ASCO 2020](https://illinoiscancercare.com/news/illinois-cancercare-presents-at-asco-2020/): May 29-31, 2020 | The American Society of Clinical Oncology (ASCO) hosted its 2020 ASCO Annual Meeting virtually. ASCO is the world’s leading professional organization of physicians and oncology professionals dedicated to conquering cancer through research, education, and quality patient care. Over 45,000 health professionals attend this annual meeting to review and discuss cutting-edge cancer research, life-changing therapies, and state-of-the-art treatments.
- [Illinois CancerCare-Making it happen in the Midwest!](https://illinoiscancercare.com/news/illinois-cancercare-making-it-happen-in-the-midwest/): Peoria, IL May 19, 2020 - For the first part of 2020, Heartland NCORP was the #1 enrolling NCORP in the Alliance for Clinical Trials in Oncology and the #2 overall enroller, only behind Harvard Medical School's affiliated Dana Farber/Partner's Health. Heartland NCORP also had the highest score for data quality among the top ten enrolling sites.
- [National Cancer Research Month: Why Research Matters](https://illinoiscancercare.com/news/national-cancer-research-month-why-research-matters/): You may have noticed that research was mentioned several times in the previous article about bladder cancer. That’s because research continues to improve the ways we prevent, diagnose and treat cancer. Coincidentally, May is also National Cancer Research Month.
- [What You Need to Know About Bladder Cancer](https://illinoiscancercare.com/news/what-you-need-to-know-about-bladder-cancer/): Bladder cancer is one of those diseases that is somewhat under the radar … until someone you love gets it. That’s why we’re highlighting it during Bladder Cancer Awareness Month, which is recognized every May.
- [Illinois CancerCare Spring 2020 Newsletter](https://illinoiscancercare.com/news/illinois-cancercare-spring-2020-newsletter/)
- [Illinois CancerCare First in the State to Bring New Breast Cancer Research](https://illinoiscancercare.com/news/illinois-cancercare-first-in-the-state-to-bring-new-breast-cancer-research/): Peoria, IL, April 27, 2020 - What does access to cutting edge care look like for a type of breast cancer that currently has no cure? At Illinois CancerCare, it means access to the most current research. And today, it means a new hope for patients diagnosed with a certain form of breast cancer that has spread to the brain. Illinois CancerCare is proud to be currently the ONLY practice in Illinois offering a new clinical trial to this group of breast cancer patients - HER2CLIMB-02.
- [Patient Newsletter: January – March 2020](https://illinoiscancercare.com/news/patient-newsletter-january-march-2020/): Take a look inside!
- [Help Advance Cancer Treatment for African American Women](https://illinoiscancercare.com/news/help-advance-cancer-treatment-for-african-american-women/): Are you a Black woman with breast cancer? Ask your doctor if you are eligible for a study that seeks to improve treatment outcomes and decrease tingling, numbness, pain, muscle weakness (neuropathy) caused by some chemotherapy drugs.
- [First Advancement for Pancreatic Cancer Treatment in 10 years Comes as Result of Genetic Testing](https://illinoiscancercare.com/news/first-advancement-for-pancreatic-cancer-treatment-in-10-years-comes-as-result-of-genetic-testing/): Pancreatic cancer has the reputation of being one of the toughest cancers to treat, and yet clinical cancer research is equally relentless in its search for better treatments and a cure. The current trend in cancer treatment has been personalized therapy.  Physicians are genetically testing more and more people to see why they have cancer and realizing that different genetic abnormalities of the same type of cancer are going to be treated very differently. In the case of pancreatic cancer, this has led to the first advancement in treatment seen in 10 years.
- [From the Heart – A Profile in Kindness](https://illinoiscancercare.com/news/from-the-heart/): “You really see the human strength and spirit,” Joanne Woiwode says of the time she spends volunteering with patients at Illinois CancerCare almost every Thursday.
- [What I Wish I’d Known Then](https://illinoiscancercare.com/news/what-i-wish-id-known-then/): With two daughters in college, Gayle Siems immediately thought of her family when she was diagnosed with breast cancer in early December of 2018. That Tuesday, Gayle and her husband, Brian, had gone to her call-back appointment at the Susan G. Komen Breast Cancer Center anticipating that it was just a fluke and she’d simply need more frequent follow-ups.
- [FDA Approves New Treatment](https://illinoiscancercare.com/news/fda-approves-new-treatment/): 12/3/2019 | Genentech announced the FDA approval of Tecentriq (atezolizumab) in combination with chemotherapy agents Abraxane and Carboplatin for the initial treatment of adults with metastatic non-squamous non-small cell lung cancer. This new treatment has shown to benefit patients by preventing their cancer from worsening over a longer period of time and improving survival.
- [Research Update: Lenalidomide Has Significant Impact on Smoldering Multiple Myeloma](https://illinoiscancercare.com/news/research-update-lenalidomide-has-significant-impact-on-smoldering-multiple-myeloma/): Results from clinical research trial E3A06 show that treatment with Lenalidomide significantly lowers the risk of disease worsening from smoldering multiple myeloma to active multiple myeloma in intermediate and high-risk patients. Smoldering multiple myeloma (SMM) is an early, precancerous form of multiple myeloma (MM). The risk of SMM progressing to MM increases over time and occurs sooner for intermediate and high-risk patients (2-5 years from diagnosis).
- [Results from Largest Breast Treatment Trial Exceed Expectations](https://illinoiscancercare.com/news/results-from-largest-breast-treatment-trial-exceed-expectations/): Illinois CancerCare Research Patients Contribute!
- [For The Gents: What You Need to Know About Prostate Cancer](https://illinoiscancercare.com/news/for-the-gents-what-you-need-to-know-about-prostate-cancer/): During September, the cancer community highlights two gender-specific cancers – prostate and ovarian. We’ll focus on prostate cancer in this month’s article and will highlight ovarian cancer in a future post.
- [How a Stranger Saved Her Life](https://illinoiscancercare.com/news/how-a-stranger-saved-her-life/): It was the summer of 2012 and life was good for the Leuba family. Sean, Maureen and their three sons were preparing to move to China for a job transfer.
- [Protect The Skin You’re In](https://illinoiscancercare.com/news/protect-the-skin-youre-in/): As we recognize National Cancer Survivor Month and celebrate the great strides being made in helping people live longer, we really need to talk about skin cancer.
- [Vitrakvi Meets FDA Approval](https://illinoiscancercare.com/news/vitrakvi-meets-fda-approval/): https://youtu.be/GZMjLfF5TXc
- [April/May/June 2019 Patient Newsletter](https://illinoiscancercare.com/news/april-may-june-2019-patient-newsletter/): Articles Inside:
- [Kenne & Desi’s Story](https://illinoiscancercare.com/news/kenne-desis-story/): It started with an email from our Illinois CancerCare physician Dr. Kumar, “I learnt of an amazing series of events in the Bloomington office yesterday… I have suspected that there are saintly people in the world, I did not know that they are this close to us.” The story that unfolded was one that would prove this statement true…
- [Dr. Paul Fishkin Announces New Way to Treat Prostate Cancer](https://illinoiscancercare.com/news/dr-paul-fishkin-announces-new-way-to-treat-prostate-cancer/): https://youtu.be/N7zyiY9n83Q
- [Tips to Stay Healthy](https://illinoiscancercare.com/news/stay-healthy/): The best way to assure your love ones of your presence for many years to come is to make choices that help you stay healthy and avoid diseases like cancer. At Illinois CancerCare, we encourage you to shift some energy from everyday life toward developing healthy habits and scheduling recommended healthcare screenings.
- [Cancer Doesn’t Take a Holiday – And Neither Does Compassion](https://illinoiscancercare.com/news/holiday/): Some people are like bouncy little kids during the holidays. Others prefer to sit back and absorb the magic of the season. Some struggle to get through this time of year, for any number of reasons.
- [The Impact of Pancreatic Cancer](https://illinoiscancercare.com/news/pancreatic-cancer/): The statistics are brutal: the five-year survival rate for people with pancreatic cancer is only 8%.1 But we’re not willing to accept these dismal rates. That’s why we’re working to find ways to identify pancreatic cancer sooner, which can lead to improved survival rates.
- [Immunotherapy Offers Promise to Cancer Patients](https://illinoiscancercare.com/news/immunotherapy/): The Nobel Prize is a big deal—a REALLY big deal. And this year, the Nobel Prize is especially meaningful to all of us at Illinois CancerCare (ILCC).
- [Understanding Palliative Care](https://illinoiscancercare.com/news/palliative-care/): Palliative care is often misunderstood and confused with hospice care. Both offer services designed to increase comfort while also reducing the pain, suffering and emotional stress that critically ill patients experience.
- [Cancer Treatment and You](https://illinoiscancercare.com/news/cancer-treatment/): “We know cancer treatment can be overwhelming,” Tammy Daily, APN says. “But we are 100% committed to helping you be prepared so you know what to expect.”
- [October/November/December                                   2018 Patient Newsletter](https://illinoiscancercare.com/news/october-november-december-2018-patient-newsletter/): Articles Inside:
- [Treating More Than Just Cancer](https://illinoiscancercare.com/news/treating-more-than-just-cancer/): Did you know that 30% of the patients at Illinois CancerCare don’t have cancer? Cindi H. was surprised when she first found out. “I was so glad when I realized that the nice people at Illinois CancerCare were able to treat my iron deficiency anemia,” Cindi said. “Dr. Gerstner and the whole Illinois CancerCare team have taken such great care of me that I can’t imagine going anywhere else.”
- [Advances in Melanoma Treatment](https://illinoiscancercare.com/news/advances-in-melanoma-treatment/): Skin cancer is the most common cancer in the United States. There are three main types, including basal cell carcinomas (BCC) and squamous cell carcinomas (SCC), which are very common. Although these cancers are malignant, they’re unlikely to spread to other parts of the body, which makes them very treatable, especially when caught early.
- [Colorectal Cancer Screening: What You Need To Know](https://illinoiscancercare.com/news/colon-cancer-guidelines/): Let’s face it. Reading about colorectal screening isn’t high on anyone’s “favorite things” list. But because of your favorite things—like your spouse, kids, pets, business, and hobbies—this is a very important article to read.
- [From Here to There: How a New Drug is Created, Tested, and Delivered](https://illinoiscancercare.com/news/trials/): A common misconception about clinical trials is that pharmaceutical companies are completely responsible for testing the drugs they develop. Although most clinical trials are sponsored and funded by pharmaceutical companies, the study itself is conducted in the community, including practices like Illinois CancerCare. Groups like Illinois CancerCare, through Heartland Cancer Research NCORP1, pharmaceutical sponsors, and consortiums, conduct and document drug research using a carefully-designed protocol that has been approved by an Institutional Review Board (IRB).
- [Nationally Recognized Research Program Receives Several Awards](https://illinoiscancercare.com/news/nationally-recognized-research-program-receives-several-awards/): Illinois CancerCare has a nationally recognized research program and has received several awards, including the ASCO Clinical Trials Participation Award and is the top enroller in cooperative group programs.
- [Your Friend Has Cancer: What to Do, What to Say](https://illinoiscancercare.com/news/friend-has-cancer/): Your friend has cancer. You want to help, but you don’t know how.
- [July/August/September 2018 Patient Newsletter](https://illinoiscancercare.com/news/july-august-september-2018-patient-newsletter/): Articles Inside:Serving You With Our Oncology PharmacySwing for the Cure 2018Senara Mayk-Overs & MargaritasIllinois CancerCare staff attend National Research ConferenceBalancing Your Cancer with Your LifeCancer Fighting Black Bean Quesadilla RecipeIvan Pfautsch shadows Dr. GeoffroyPrinceton Brownies Serve Girl Scout Cookies
- [Serving You with Our Oncology Pharmacy](https://illinoiscancercare.com/news/oncology-pharmacy/): When faced with a battle against cancer, you need a comprehensive, collaborative, first-rate team to help optimize your treatment and minimize your discomfort. A specially-trained oncology pharmacist is a vital and active member of this team.
- [Balancing Your Cancer With Your Life](https://illinoiscancercare.com/news/balancing-cancer-life/): In today’s world, it can be hard to find balance in our lives. This is especially true for cancer patients and their families.
- [New Report finds most women with a common type of early-stage breast cancer can skip chemo](https://illinoiscancercare.com/news/new-report-finds-most-women-with-a-common-type-of-early-stage-breast-cancer-can-skip-chemo/): Recent research has found that most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease.  This landmark study, recently published in the New England School of Medicine shows that most women will not need treatment beyond surgery and hormone therapy.
- [Clinical Trial Shows Use of Drug During Chemotherapy Reduces Nausea and Vomiting](https://illinoiscancercare.com/news/heartland-cancer-research-ncorpillinois-cancercare-participates-clinical-trial/): The Illinois CancerCare component of the Heartland Cancer Research NCORP is proud to announce clinical trial results showing that 86% of the patients receiving chemotherapy known to cause high levels of nausea tolerated the treatment considerably better.
- [First Patient in Nation Enrolled in Clinical Trial for Treatment of Metastatic Melanoma](https://illinoiscancercare.com/news/first-patient-nation-entrolled-clinical-trial-treatment-metastatic-melanoma/): This trial is designed to assess the efficacy, safety, and tolerability when combining pembrolizumab, which strengthens the immune system to help fight the cancer cells, with epacadostat, a highly effective drug that reverses immune suppression and restores the immune system’s ability to recognize the cancer cells.
- [Illinois CancerCare Enrolls First Patients in the World in Clinical Trials for Treatment of Lung Cancer](https://illinoiscancercare.com/news/illinois-cancercare-enrolls-first-patients-world-clinical-trials-treatment-lung-cancer/): Illinois CancerCare announced enrollment of the first patients in the world in two clinical trials that are studying the efficacy and safety in the treatment of lung cancer.

## Clinical Trials
- [SCRI V940-009](https://illinoiscancercare.com/current-trials/scri-v940-009/)
- [S2506 (JIT)](https://illinoiscancercare.com/current-trials/s2506-jit/)
- [EAA232](https://illinoiscancercare.com/current-trials/eaa232/)
- [EAQ222CD](https://illinoiscancercare.com/current-trials/eaq222cd/)
- [SCRI V940-014](https://illinoiscancercare.com/current-trials/scri-v940-014/)
- [S2511](https://illinoiscancercare.com/current-trials/s2511/)
- [S1900N](https://illinoiscancercare.com/current-trials/s1900n/)
- [MM1OA-S04](https://illinoiscancercare.com/current-trials/mm1oa-s04/)
- [SCRI KER-050-D301](https://illinoiscancercare.com/current-trials/scri-ker-050-d301/)
- [SCRI MS914001_0002](https://illinoiscancercare.com/current-trials/scri-ms914001_0002/)
- [A082302](https://illinoiscancercare.com/current-trials/a082302/)
- [HN016](https://illinoiscancercare.com/current-trials/hn016/)
- [S2504](https://illinoiscancercare.com/current-trials/s2504/)
- [SCRI IMM1104-301](https://illinoiscancercare.com/current-trials/scri-imm1104-301/)
- [SCRI BNT324-03](https://illinoiscancercare.com/current-trials/scri-bnt324-03/)
- [A082402](https://illinoiscancercare.com/current-trials/a082402/)
- [CC017](https://illinoiscancercare.com/current-trials/cc017/)
- [EA1242](https://illinoiscancercare.com/current-trials/ea1242/)
- [S2419](https://illinoiscancercare.com/current-trials/s2419/)
- [A072301](https://illinoiscancercare.com/current-trials/a072301/)
- [SCRI C6461016](https://illinoiscancercare.com/current-trials/scri-c6461016/)
- [SCRI OP-1250-302](https://illinoiscancercare.com/current-trials/scri-op-1250-302/)
- [A042302](https://illinoiscancercare.com/current-trials/a042302/)
- [A212101](https://illinoiscancercare.com/current-trials/a212101/)
- [SCRI CA2660001](https://illinoiscancercare.com/current-trials/scri-ca2660001/)
- [SCRI ZL-1310-003](https://illinoiscancercare.com/current-trials/zl-1310-003/)
- [SN2426- JIT](https://illinoiscancercare.com/current-trials/sn2426-jit/)
- [S2433](https://illinoiscancercare.com/current-trials/s2433/)
- [A232402CD](https://illinoiscancercare.com/current-trials/a232402cd/)
- [SCRI C5851005](https://illinoiscancercare.com/current-trials/scri-c5851005/)
- [SCRI C6461001](https://illinoiscancercare.com/current-trials/scri-c6461001/)
- [SCRI MK2140-011](https://illinoiscancercare.com/current-trials/scri-mk2140-011/)
- [SCRI C6461003](https://illinoiscancercare.com/current-trials/scri-c6461003/)
- [S2427](https://illinoiscancercare.com/current-trials/s2427/)
- [CCTG-PR26](https://illinoiscancercare.com/current-trials/cctg-pr26/)
- [S2101](https://illinoiscancercare.com/current-trials/s2101/)
- [A081801](https://illinoiscancercare.com/current-trials/a081801/)
- [SCRI 61186372COR3001](https://illinoiscancercare.com/current-trials/scri-61186372cor3001/)
- [SCRI 61186372COR3002](https://illinoiscancercare.com/current-trials/scri-61186372cor3002/)
- [SCRI 61186372NSC2012 (COPERNICUS)](https://illinoiscancercare.com/current-trials/sci-61186372nsc2012/)
- [SCRI DS1062-328](https://illinoiscancercare.com/current-trials/scri-ds1062-328/)
- [A032302](https://illinoiscancercare.com/current-trials/a032302/)
- [URCC 24060](https://illinoiscancercare.com/current-trials/urcc-24060/)
- [GI011](https://illinoiscancercare.com/current-trials/gi011/)
- [A232301CD](https://illinoiscancercare.com/current-trials/a232301cd/)
- [A012303](https://illinoiscancercare.com/current-trials/a012303/)
- [S2417CD](https://illinoiscancercare.com/current-trials/s2417cd/)
- [A222301](https://illinoiscancercare.com/current-trials/a222301/)
- [S2414 (JIT)](https://illinoiscancercare.com/current-trials/s2414-jit/)
- [CC014](https://illinoiscancercare.com/current-trials/cc014/)
- [MM1MDS-A01 (MYELOMATCH)](https://illinoiscancercare.com/current-trials/mm1mds-a01/)
- [EAA173](https://illinoiscancercare.com/current-trials/eaa173/)
- [LUNGMAP](https://illinoiscancercare.com/current-trials/lungmap/)
- [S1800E](https://illinoiscancercare.com/current-trials/s1800e/)
- [EA5231 (Temporarily Closed)](https://illinoiscancercare.com/current-trials/ea5231/)
- [CCTG-BR38](https://illinoiscancercare.com/current-trials/cctg-br38/)
- [TP-CA-005](https://illinoiscancercare.com/current-trials/tp-ca-005/)
- [EA2174 (Suspended)](https://illinoiscancercare.com/current-trials/ea2174-suspened/)
- [DCP-001](https://illinoiscancercare.com/current-trials/dcp-001/)
- [CC015](https://illinoiscancercare.com/current-trials/cc015/)
- [A072201](https://illinoiscancercare.com/current-trials/a072201-suspended/)
- [SMT112-3003](https://illinoiscancercare.com/current-trials/smt112-3003/)
- [A032201](https://illinoiscancercare.com/current-trials/a032201/)
- [WF2304-A172401](https://illinoiscancercare.com/current-trials/wf2304-a172401/)
- [A092205](https://illinoiscancercare.com/current-trials/a092205/)
- [CA245-0001](https://illinoiscancercare.com/current-trials/bms-ca245-0001/)
- [TP-CA-006](https://illinoiscancercare.com/current-trials/tp-ca-006/)
- [MK-5684-004](https://illinoiscancercare.com/current-trials/mk-5684-004/)
- [A032102](https://illinoiscancercare.com/current-trials/a032102/)
- [EAY191-COMBOMATCH](https://illinoiscancercare.com/current-trials/eay191-combomatch/)
- [PRECEDE](https://illinoiscancercare.com/current-trials/precede/)
- [WF-1806](https://illinoiscancercare.com/current-trials/wf-1806/)
- [EAY191-A6 (JIT Trial)](https://illinoiscancercare.com/current-trials/eay191-a6-jit-trial/)
- [01-PS-001](https://illinoiscancercare.com/current-trials/01-ps-001/)
- [R3767-ONC-22122](https://illinoiscancercare.com/current-trials/r3767-onc-22122/)
- [S1900J](https://illinoiscancercare.com/current-trials/s1900j/)
- [APG2575CG301](https://illinoiscancercare.com/current-trials/apg2575cg301/)
- [S2312](https://illinoiscancercare.com/current-trials/s2312/)
- [EA7222](https://illinoiscancercare.com/current-trials/ea7222/)
- [TP-CA-007](https://illinoiscancercare.com/current-trials/tp-ca-007/)
- [MM1MDS-A01 (MYELOMATCH)](https://illinoiscancercare.com/current-trials/myelomatch/)
- [EAY191-N5 (JIT)](https://illinoiscancercare.com/current-trials/eay191-n5-jit/): EA
- [A032103](https://illinoiscancercare.com/current-trials/a032103/)
- [S1900G](https://illinoiscancercare.com/current-trials/s1900g/)
- [S1900K](https://illinoiscancercare.com/current-trials/s1900k/)
- [S2206](https://illinoiscancercare.com/current-trials/s2206/)
- [URCC-22063](https://illinoiscancercare.com/current-trials/urcc-22063/)
- [S2212](https://illinoiscancercare.com/current-trials/s2212/)
- [A012103](https://illinoiscancercare.com/current-trials/a012103/)
- [WF-2201](https://illinoiscancercare.com/current-trials/wf-2201/)
- [J2J-MC-JZLH/EMBER 4](https://illinoiscancercare.com/current-trials/j2j-mc-jzlh/)
- [EA2192](https://illinoiscancercare.com/current-trials/ea2192/)
- [TP-CA-003](https://illinoiscancercare.com/current-trials/tp-ca-003/)
- [GI008](https://illinoiscancercare.com/current-trials/gi008/)
- [S2013](https://illinoiscancercare.com/current-trials/s2013/)